5 Insightful Analyst Questions From NN's Q2 Earnings Call

NN’s second quarter results reflected a challenging market environment, particularly in the automotive segment, with sales declining year-over-year and missing Wall Street revenue expectations. Management attributed most of the sales shortfall to a major European automotive customer, while ongoing portfolio rationalization and cost initiatives helped maintain operating margins. CEO Harold Bevis highlighted the company’s ability to improve gross margins and win new business, stating, “We have launched over 70 new programs year-to-date and have more to go.”

Is now the time to buy NNBR? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From NN’s Q2 Earnings Call

• Robert Duncan Brown (Lake Street Capital): Asked about incremental margins from new business wins and verticals driving share gains. CEO Harold Bevis explained wins are accretive by 3-4 points on EBITDA, with growth focused on electrical and medical segments.
• John Edward Franzreb (Sidoti & Company): Questioned how NN plans to achieve second-half revenue guidance without a market rebound. Bevis and CFO Chris Bohnert said guidance depends on new program launches, not base market growth, and acknowledged risks if launches are delayed.
• Michael Roy Crawford (B. Riley Securities): Inquired about progress in on-time delivery and dedicated medical equipment utilization. COO Tim French reported all customer scorecards are now positive, enabling new business wins, and Bevis said medical production capacity could double current revenue.
• Hans Baldau (NOBLE Capital Markets): Asked about the new M&A program’s focus. Bevis detailed targeted acquisitions aligned with existing strategy, with an emphasis on synergies and strengthening the company’s balance sheet.
• Barry George Haimes (Sage Asset Management): Queried the impact of tariffs and reshoring on the business pipeline. Bevis described increased RFQs from customers rethinking supply chains, especially in automotive, and noted NN’s pass-through agreements limit direct tariff impact.

Catalysts in Upcoming Quarters

In coming quarters, the StockStory team will be monitoring (1) the pace and successful execution of new business program launches, (2) further progress in margin expansion from cost reduction efforts, and (3) the impact of targeted investments in medical and electrical market growth. Additional attention will be paid to M&A developments and NN’s ability to offset market volatility through portfolio diversification.

NN currently trades at $2.40, up from $2.15 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.